Analyzing iShares Biotechnology ETF (NASDAQ:IBB) & ASA Gold and Precious Metals (NYSE:ASA)

iShares Biotechnology ETF (NASDAQ:IBBGet Free Report) and ASA Gold and Precious Metals (NYSE:ASAGet Free Report) are both finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, earnings, dividends, analyst recommendations, institutional ownership, risk and valuation.

Insider and Institutional Ownership

62.5% of iShares Biotechnology ETF shares are owned by institutional investors. 0.3% of ASA Gold and Precious Metals shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Earnings & Valuation

This table compares iShares Biotechnology ETF and ASA Gold and Precious Metals’ top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
iShares Biotechnology ETF N/A N/A N/A N/A N/A
ASA Gold and Precious Metals N/A N/A N/A N/A N/A

Analyst Recommendations

This is a breakdown of current ratings and price targets for iShares Biotechnology ETF and ASA Gold and Precious Metals, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
iShares Biotechnology ETF 0 8 7 0 2.57
ASA Gold and Precious Metals 0 0 0 0 N/A

Given iShares Biotechnology ETF’s higher probable upside, equities analysts clearly believe iShares Biotechnology ETF is more favorable than ASA Gold and Precious Metals.

Risk & Volatility

iShares Biotechnology ETF has a beta of 0.75, suggesting that its stock price is 25% less volatile than the S&P 500. Comparatively, ASA Gold and Precious Metals has a beta of 1.2, suggesting that its stock price is 20% more volatile than the S&P 500.

Dividends

iShares Biotechnology ETF pays an annual dividend of $0.40 per share and has a dividend yield of 0.3%. ASA Gold and Precious Metals pays an annual dividend of $0.03 per share and has a dividend yield of 0.2%.

Profitability

This table compares iShares Biotechnology ETF and ASA Gold and Precious Metals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
iShares Biotechnology ETF N/A N/A N/A
ASA Gold and Precious Metals N/A N/A N/A

Summary

iShares Biotechnology ETF beats ASA Gold and Precious Metals on 4 of the 6 factors compared between the two stocks.

About iShares Biotechnology ETF

(Get Free Report)

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ. The Fund invests in a representative sample of securities included in the Index that collectively has an investment profile similar to the Index. Due to the use of representative sampling, the Fund may or may not hold all of the securities that are included in the Index. The Fund’s investment advisor is BlackRock Fund Advisors, which is indirectly owned by BlackRock, Inc.

About ASA Gold and Precious Metals

(Get Free Report)

ASA Gold and Precious Metals Limited is a publicly owned investment manager. The firm invests in the public equity markets across the globe. It primarily invests in stocks of companies engaged in the exploration, mining or processing of gold, silver, platinum, diamonds, or other precious minerals. It also invests in exchange traded funds. The firm employs fundamental analysis with a bottom-up approach to create its portfolios. The firm obtains external research to complement its in-house research. The firm is focused on covering the metals and mining sector. This record reflects the investment preferences or overall investment strategy of ASA Gold and Precious Metals Limited. ASA Gold and Precious Metals Limited was founded in 1958 and is based in Portland, Maine.

Receive News & Ratings for iShares Biotechnology ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Biotechnology ETF and related companies with MarketBeat.com's FREE daily email newsletter.